FDA warns about misleading advertising for some laser eye surgeries

FDA warns about misleading advertising for some laser eye surgeries
Five companies told to do better job of including risks of procedures such as LASIK.

(HealthDay)—Five U.S. eye care providers have been warned to stop misleading advertising about the special lasers used in vision correction procedures such as LASIK, the U.S. Food and Drug Administration said Tuesday.

Those ads and promotional materials do not offer consumers enough information about the potential risks, according to the FDA.

"Advertising by many care professionals who perform laser vision correction surgery provides patients with the risk information that they need to make informed decisions," Steve Silverman, compliance director at FDA's Center for Devices and Radiological Health, said in an agency news release. "But providers whose advertising does not provide adequate risk information are finding out today that the FDA is serious about consumer protection."

The FDA said the warnings were sent to: 20/20 Institute Indianapolis LASIK, in Indianapolis; Scott Hyver Visioncare Inc., in Daly City, Calif.; Rand Eye Institute, in Deerfield Beach, Fla.; Eye Center of Texas, in Bellaire; and Woolfson Eye Institute, in Atlanta.

If the providers do not correct their advertising and promotional materials to address the FDA's concerns, the agency may take further action, including seizures, injunctions and fines, the agency said in its news release.

The most common risks of LASIK surgery include: , which can be severe; the possible need for glasses or contact lenses after surgery; vision problems such as halos, glare, starbursts; double vision; and loss of vision.

In May 2009 and September 2001, the FDA issued letters to eye care professionals nationwide outlining the agency's concerns about improper advertising and promotion of .

More information: The MedlinePlus Medical Encyclopedia has more about LASIK eye surgery.

add to favorites email to friend print save as pdf

Related Stories

FDA to study negative effects of Lasik eye surgery

Oct 16, 2009

(AP) -- The Food and Drug Administration announced plans Thursday to study the scope of problems connected with laser eye-correcting surgery, which include blurred vision and dry eyes.

FDA approves new LASIK device

Jul 12, 2007

The U.S. Food and Drug Administration has approved the first LASIK device designed to treat one eye for distance vision and the other eye for close vision.

FDA urges docs to report misleading drug ads

May 11, 2010

(AP) -- The Food and Drug Administration said Tuesday it will begin asking doctors to keep an eye out for misleading drug advertisements as part of the agency's latest effort to police the pharmaceutical industry's multibillion-dollar ...

Recommended for you

Man among first in US to get 'bionic eye' (Update)

Apr 23, 2014

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure ...

Training can improve visual field losses from glaucoma

Apr 17, 2014

(HealthDay)—Visual field loss from glaucoma is in part reversible by behavioral, computer-based, online controlled vision training, according to a study published in the April issue of JAMA Ophthalmology.

Fewer ophthalmologists equals less diabetic eye care

Apr 15, 2014

(HealthDay)—In areas with less access to ophthalmologists, fewer individuals with diabetes, diabetic retinopathy, and age-related macular degeneration (ARMD) receive care, according to a study published ...

User comments